A5003684141- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Influenza Virus Research Studies
- Bacterial Infections and Vaccines
- Respiratory and Cough-Related Research
- Viral gastroenteritis research and epidemiology
- Streptococcal Infections and Treatments
- Pediatric health and respiratory diseases
- Vaccine Coverage and Hesitancy
- Pneumocystis jirovecii pneumonia detection and treatment
- Neonatal Respiratory Health Research
- Viral Infections and Immunology Research
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- Cystic Fibrosis Research Advances
- Tracheal and airway disorders
- Antibiotics Pharmacokinetics and Efficacy
- Neonatal and Maternal Infections
- Asthma and respiratory diseases
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- Ear Surgery and Otitis Media
- Diabetes and associated disorders
- Antimicrobial Resistance in Staphylococcus
- Infectious Diseases and Tuberculosis
Barilla (Italy)
2019-2025
University of Parma
2010-2025
Fondazione Poliambulanza Istituto Ospedaliero
2025
Ospedale di Parma
2021-2024
Istituto Nazionale di Fisica Nucleare, Sezione di Bari
2024
University of Milan
2012-2022
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2012-2022
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2021
Azienda Ospedaliero Universitario Mater Domini
2017-2021
Azienda Unita' Sanitaria Locale Di Modena
2021
BackgroundThe Global Point Prevalence Survey (Global-PPS) established an international network of hospitals to measure antimicrobial prescribing and resistance worldwide. We aimed assess in hospital inpatients.MethodsWe used a standardised surveillance method collect detailed data about from worldwide, which were grouped by UN region. The internet-based survey included all inpatients (adults, children, neonates) receiving who on the ward at 0800 h one specific day between January September,...
<h3>Context</h3>In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause invasive disease in early childhood developed countries.<h3>Objective</h3>To determine immunogenicity and reactogenicity multicomponent MenB vaccine (4CMenB) routine infant vaccines when given either concomitantly or separately.<h3>Design, Setting, Participants</h3>Phase 2b, multicenter, open-label, parallel-group, randomized controlled study 1885 infants enrolled at age 2...
An Effective Intervention at the Global Level?In most countries, attempts to reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulation and new disease 2019 (COVID-19) development have been mainly based on restrictive measures, including avoidance of social interactions, prohibition movements within national territory, closureofallnonessentialactivities,includingschools.While closure factories other interaction together with proper hand washing remain best measures total...
Although data on the incidence and severity of new coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome 2 (SARS-CoV-2) infection showed more significant among adults elderly, a clinical manifestation characterized by multisystem inflammatory was described in children (MIS-C). It initially thought be specific children, but recent reports have shown that it can also occur adults. MIS-C is number multisystemic manifestations resembling other known previously illnesses,...